1.
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
by Hessell, Ann J
Nature medicine, 2016, Vol.22 (4), p.362-368
2.
Fc receptor but not complement binding is important in antibody protection against HIV
by Burton, Dennis R
Nature (London), 2007, Vol.449 (7158), p.101-104
3.
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
by Liu, Jinyan
Nature, 2009, Vol.457 (7225), p.87-91
4.
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
by Fukazawa, Yoshinori
Nature medicine, 2015, Vol.21 (2), p.132-139
5.
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
by Ackerman, Margaret E
Nature medicine, 2018, Vol.24 (10), p.1590-1598
6.
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection
by Gautam, Rajeev
Nature medicine, 2018, Vol.24 (5), p.610-616
7.
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
by Vaccari, Monica
Nature medicine, 2016, Vol.22 (7), p.762-770
8.
Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection
by Roederer, Mario
Nature, 2005, Vol.434 (7037), p.1093-1097
9.
Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz
by Rudicell, Rebecca S
Nature (London), 2009, Vol.460 (7254), p.515-519
10.
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
by Harper, Justin
Nature medicine, 2020, Vol.26 (4), p.519-528
11.
Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
by Bäumler, Andreas J
Nature medicine, 2008, Vol.14 (4), p.421-428
12.
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
by Hessell, Ann J
Nature medicine, 2009, Vol.15 (8), p.951-954
13.
Early events in sexual transmission of HIV and SIV and opportunities for interventions
by Haase, Ashley T
Annual review of medicine, 2011, Vol.62 (1), p.127-139
14.
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
by Johnson, Philip R
Nature medicine, 2009, Vol.15 (8), p.901-906
15.
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
by Fukazawa, Yoshinori
Nature medicine, 2012, Vol.18 (11), p.1673-1681
16.
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
by Byrareddy, Siddappa N
Nature medicine, 2014, Vol.20 (12), p.1397-1400
17.
Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts
by Silvestri, Guido
Nature medicine, 2009, Vol.15 (8), p.861-865
18.
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge
by Sholukh, Anton M
Vaccine, 2015, Vol.33 (17), p.2086-2095
19.
Enhancing SIV-specific immunity in vivo by PD-1 blockade
by Vanderford, Thomas H
Nature, 2009, Vol.458 (7235), p.206-210
20.
Inadequate T follicular cell help impairs B cell immunity during HIV infection
by Cubas, Rafael A
Nature medicine, 2013, Vol.19 (4), p.494-499
